Mirae Asset Global Investments Co., Ltd. Cytokinetics Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,613 shares of CYTK stock, worth $271,982. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,613
Previous 3,930
17.38%
Holding current value
$271,982
Previous $157,000
3.18%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CYTK
# of Institutions
378Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.04 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$865 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$707 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$462 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$376 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.55B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...